NovoCure Limited
Organization details
- Legal name
- NovoCure Limited
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Headquarters city
- ST. Helier
- Headquarters country
- Jersey
- Fiscal year end
- December
- Ticker symbol
- NVCR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001645113
Board of directors
-
Allyson J. Ocean · DirectorSince 2023
-
Asaf Danziger · Director · Chief Executive OfficerSince 2023
-
David Hung · DirectorSince 2023
-
Gabriel Leung · DirectorSince 2023
-
Jeryl L. Hilleman · DirectorSince 2023
-
Kristin Stafford · DirectorSince 2023
-
Martin J. Madden · DirectorSince 2023
-
Timothy J. Scannell · DirectorSince 2023
-
W. Anthony Vernon · DirectorSince 2023
-
William F. Doyle · Director · Executive ChairmanSince 2026
Chief executives
Director election results
Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.8%
-
97.5%
-
98.0%
-
98.2%
-
98.2%
-
98.3%
-
98.4%
-
98.4%
-
98.5%
Board connections
6 of this board's directors also sit on 9 other boards. 8 are in the same sector.
-
Nuvation Bio Inc. Same sectorvia David Hung and W. Anthony Vernon
-
Elanco Animal Health Incorporated Same sectorvia William F. Doyle
-
Insulet Corporation Same sectorvia Timothy J. Scannell
- via W. Anthony Vernon
-
Microbot Medical Inc. Same sectorvia Martin J. Madden
-
Minerva Neurosciences Inc Same sectorvia Jeryl L. Hilleman
-
Omada Health Inc. Same sectorvia Jeryl L. Hilleman
-
ProKidney Corp. Same sectorvia William F. Doyle
-
SI-BONE Inc. Same sectorvia Jeryl L. Hilleman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $3,260,989
- 26 sales by 14 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Puri Michal Nath Officer (Chief Human Resources Officer) | Open-market sale | −660 | $13.24 | $8,738 |
| Jun 30, 2026 | Ben Arye Barak Officer (General Counsel) | Grant or award | +1,299 | $11.15 | $14,484 |
| Jun 30, 2026 | Asaf Danziger Director | Grant or award | +268 | $11.15 | $2,988 |
| Jun 30, 2026 | Leonard Frank X Officer (Chief Executive Officer) | Grant or award | +1,905 | $11.15 | $21,241 |
| Jun 30, 2026 | Puri Michal Nath Officer (Chief Human Resources Officer) | Grant or award | +1,905 | $11.15 | $21,241 |
| Jun 4, 2026 | Leonard Frank X Officer (Chief Executive Officer) | Open-market sale | −34,273 | $17.93 | $614,515 |
| Jun 3, 2026 | Gabriel Leung Director | Grant or award | +11,610 | — | — |
| Jun 3, 2026 | Kristin Stafford Director | Grant or award | +11,610 | — | — |
| Jun 3, 2026 | Allyson J. Ocean Director | Grant or award | +11,610 | — | — |
| Jun 3, 2026 | Timothy J. Scannell Director | Grant or award | +11,610 | — | — |
| Jun 3, 2026 | Jeryl L. Hilleman Director | Grant or award | +11,610 | — | — |
| Jun 3, 2026 | David Hung Director | Grant or award | +11,610 | — | — |
| Jun 3, 2026 | Martin J. Madden Director | Grant or award | +11,610 | — | — |
| Jun 3, 2026 | W. Anthony Vernon Director | Grant or award | +11,610 | — | — |
| Jun 2, 2026 | Gabriel Leung Director | Open-market sale | −2,945 | $15.77 | $46,443 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about NovoCure Limited
Who is the CEO of NovoCure Limited?
Asaf Danziger is NovoCure Limited's Chief Executive Officer.
How many directors are on NovoCure Limited's board?
NovoCure Limited's board has 10 directors: Allyson J. Ocean, Asaf Danziger, David Hung, Gabriel Leung, Jeryl L. Hilleman, Kristin Stafford, Martin J. Madden, Timothy J. Scannell, W. Anthony Vernon and William F. Doyle.
Are NovoCure Limited insiders buying or selling shares?
Over the last 12 months, NovoCure Limited insiders made no open-market purchases and sold $3.3 million of shares in 26 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="novocure-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.